Placental ABC transporters, cellular toxicity and stress in pregnancy

Chemico-Biological Interactions

Volumn 203, Issue 2, 2013, Pages 456-466

  Aye, Irving L M H ^a   Keelan, Jeffrey A ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Active transport; Cytotoxicity; Inflammation; Oxidative stress; Placenta; Trophoblast

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER G1; BREAST CANCER RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3;

CYTOTOXICITY; HUMAN; METABOLIC STRESS; NONHUMAN; OXIDATIVE STRESS; PLACENTA CIRCULATION; PLACENTAL TRANSFER; PREGNANCY; PREGNANCY DISORDER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CYTOTOXINS; FEMALE; HUMANS; OXIDATIVE STRESS; PLACENTA; PREGNANCY; XENOBIOTICS;

ANIMALIA;

EID: 84876000008     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.03.007     Document Type: Review

References (157)

1. M.R. Syme, J.W. Paxton, and J.A. Keelan Drug transfer and metabolism by the human placenta Clin. Pharmacokinet. 43 2004 487 514
2. T. Eshkoli, E. Sheiner, Z. Ben-Zvi, and G. Holcberg Drug transport across the placenta Curr. Pharm. Biotechnol. 12 2011 707 714
3. K. Benirschke Remarkable placenta Clin. Anat. 11 1998 194 205
4. B. Huppertz The anatomy of the normal placenta J. Clin. Pathol. 61 2008 1296 1302
5. S. Kertschanska, G. Kosanke, and P. Kaufmann Is there morphological evidence for the existence of transtrophoblastic channels in human placental villi? Trophoblast Res. 8 1994 581 596
6. M. Ceckova-Novotna, P. Pavek, and F. Staud P-glycoprotein in the placenta: expression, localization, regulation and function Reprod. Toxicol. 22 2006 400 410
7. D. Evseenko, J.W. Paxton, and J.A. Keelan Active transport across the human placenta: impact on drug efficacy and toxicity Expert Opin. Drug Metab. Toxicol. 2 2006 51 69
8. D. Kolwankar, D.D. Glover, J.A. Ware, and T.S. Tracy Expression and function of ABCB1 and ABCG2 in human placental tissue Drug Metab. Dispos. 33 2005 524 529
9. P. Myllynen, E. Immonen, M. Kummu, and K. Vahakangas Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues Expert Opin. Drug Metab. Toxicol. 5 2009 1483 1499
10. M. Nagashige, F. Ushigome, N. Koyabu, K. Hirata, M. Kawabuchi, T. Hirakawa, S. Satoh, K. Tsukimori, H. Nakano, T. Uchiumi, M. Kuwano, H. Ohtani, and Y. Sawada Basal membrane localization of MRP1 in human placental trophoblast Placenta 24 2003 951 958
11. Z. Ni, and Q. Mao ATP-binding cassette efflux transporters in human placenta Curr. Pharm. Biotechnol. 12 2011 674 685
12. K. Vahakangas, and P. Myllynen Drug transporters in the human blood-placental barrier Br. J. Pharmacol. 158 2009 665 678
13. M. Dean, A. Rzhetsky, and R. Allikmets The human ATP-binding cassette (ABC) transporter superfamily Genome Res. 11 2001 1156 1166
14. I.L. Aye, A.T. Singh, and J.A. Keelan Transport of lipids by ABC proteins: interactions and implications for cellular toxicity, viability and function Chem. Biol. Interact. 180 2009 327 339
15. P. Borst, J. Balzarini, N. Ono, G. Reid, H. de Vries, P. Wielinga, J. Wijnholds, and N. Zelcer The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy Antiviral Res. 62 2004 1 7
16. M. Nishimura, and S. Naito Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies Drug Metab. Pharmacokinet. 20 2005 452 477
17. T. Litman, T.E. Druley, W.D. Stein, and S.E. Bates From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance Cell. Mol. Life Sci. 58 2001 931 959
18. A.H. Schinkel, and J.W. Jonker Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Adv. Drug Deliv. Rev. 55 2003 3 29
19. I.L. Aye, B.J. Waddell, P.J. Mark, and J.A. Keelan Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity Biochim. Biophys. Acta 2010 1801 1013 1024
20. R.T. Iborra, A. Machado-Lima, G. Castilho, V.S. Nunes, D.S. Abdalla, E.R. Nakandakare, and M. Passarelli Advanced glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1 Lipids Health Dis. 10 2011 172
21. D. Li, Y. Zhang, J. Ma, W. Ling, and M. Xia Adenosine monophosphate activated protein kinase regulates ABCG1-mediated oxysterol efflux from endothelial cells and protects against hypercholesterolemia-induced endothelial dysfunction Arterioscler. Thromb. Vasc. Biol. 30 2010 1354 1362
22. M. Xu, H. Zhou, K.C. Tan, R. Guo, S.W. Shiu, and Y. Wong ABCG1 mediated oxidized LDL-derived oxysterol efflux from macrophages Biochem. Biophys. Res. Commun. 390 2009 1349 1354
23. T. Engel, F. Kannenberg, M. Fobker, J.R. Nofer, G. Bode, A. Lueken, G. Assmann, and U. Seedorf Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol FEBS Lett. 581 2007 1673 1680
24. S.P. Tam, L. Mok, G. Chimini, M. Vasa, and R.G. Deeley ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells Am. J. Physiol. Cell Physiol. 291 2006 C490 502
25. N. Terasaka, N. Wang, L. Yvan-Charvet, and A.R. Tall High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1 Proc. Natl. Acad. Sci. USA 104 2007 15093 15098
26. S.V. Ambudkar, I.W. Kim, and Z.E. Sauna The power of the pump: mechanisms of action of P-glycoprotein (ABCB1) Eur. J. Pharm. Sci. 27 2006 392 400
27. G.M. Kalabis, A. Kostaki, M.H. Andrews, S. Petropoulos, W. Gibb, and S.G. Matthews Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection Biol. Reprod. 73 2005 591 597
28. Q. Yan, W. Sadée, Human membrane transporter database: a Web-accessible relational database for drug transport studies and pharmacogenomics. AAPS PharmSci. 2 (2000) E20.
29. D.E. Atkinson, S.L. Greenwood, C.P. Sibley, J.D. Glazier, and L.J. Fairbairn Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer Am. J. Physiol. Cell Physiol. 285 2003 C584 591
30. D.A. Evseenko, J.W. Paxton, and J.A. Keelan ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 2006 R1357 1365
31. S. Gil, R. Saura, F. Forestier, and R. Farinotti P-glycoprotein expression of the human placenta during pregnancy Placenta 26 2005 268 270
32. A.A. Mathias, J. Hitti, and J.D. Unadkat P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 2005 R963 969
33. S. Petropoulos, G.M. Kalabis, W. Gibb, and S.G. Matthews Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone Reprod. Sci. 14 2007 321 328
34. M.A. Serrano, R.I. Macias, O. Briz, M.J. Monte, A.G. Blazquez, C. Williamson, R. Kubitz, and J.J. Marin Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta Placenta 28 2007 107 117
35. P. Patel, N. Weerasekera, M. Hitchins, C.A. Boyd, D.G. Johnston, and C. Williamson Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta Placenta 24 2003 39 44
36. C. Cordon-Cardo, J.P. O'Brien, J. Boccia, D. Casals, J.R. Bertino, and M.R. Melamed Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues J. Histochem. Cytochem. 38 1990 1277 1287
37. J.J. Smit, A.H. Schinkel, C.A. Mol, D. Majoor, W.J. Mooi, A.P. Jongsma, C.R. Lincke, and P. Borst Tissue distribution of the human MDR3 P-glycoprotein Lab. Invest. 71 1994 638 649
38. G.R. Lankas, L.D. Wise, M.E. Cartwright, T. Pippert, and D.R. Umbenhauer Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice Reprod. Toxicol. 12 1998 457 463
39. J.W. Smit, M.T. Huisman, O. van Tellingen, H.R. Wiltshire, and A.H. Schinkel Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure J. Clin. Invest. 104 1999 1441 1447
40. V. Munic, Z. Kelneric, L. Mikac, and V. Erakovic Haber Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays Eur. J. Pharm. Sci. 41 2010 86 95
41. P.E. Golstein, A. Boom, J. van Geffel, P. Jacobs, B. Masereel, and R. Beauwens P-glycoprotein inhibition by glibenclamide and related compounds Pflugers Arch. 437 1999 652 660
42. M.V. St-Pierre, M.A. Serrano, R.I. Macias, U. Dubs, M. Hoechli, U. Lauper, P.J. Meier, and J.J. Marin Expression of members of the multidrug resistance protein family in human term placenta Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 2000 R1495 1503
43. J.H. Hooijberg, G.J. Peters, Y.G. Assaraf, I. Kathmann, D.G. Priest, M.A. Bunni, A.J. Veerman, G.L. Scheffer, G.J. Kaspers, and G. Jansen The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis Biochem. Pharmacol. 65 2003 765 771
44. H.E. Meyer zu Schwabedissen, G. Jedlitschky, M. Gratz, S. Haenisch, K. Linnemann, C. Fusch, I. Cascorbi, and H.K. Kroemer Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation Drug Metab. Dispos. 33 2005 896 904
45. I.L. Aye, J.W. Paxton, D.A. Evseenko, and J.A. Keelan Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes Placenta 28 2007 868 877
46. M.A. Hardy, R.T. Leonardi, and J.I. Scheide Cellular permeation pathways in a leaky epithelium: the human amniochorion Biol. Cell 66 1989 149 153
47. N. Zelcer, T. Saeki, G. Reid, J.H. Beijnen, and P. Borst Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3) J. Biol. Chem. 276 2001 46400 46407
48. L. Doyle, W. Yang, L. Abruzzo, T. Krogmann, Y. Gao, A. Rishi, and D. Ross A multidrug resistance transporter from human MCF-7 breast cancer cells Proc. Natl. Acad. Sci. USA 95 1998 15665 15670
49. M. Maliepaard, G. Scheffer, I. Faneyte, M. van-Gastelen, A. Pijnenborg, A. Schinkel, M. van-de-Vijver, R. Scheper, and J. Schellens Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res. 61 2001 3458 3464
50. Y. Zhang, H. Wang, J.D. Unadkat, and Q. Mao Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse Drug Metab. Dispos. 35 2007 2154 2158
51. J. Kraemer, J. Klein, A. Lubetsky, and G. Koren Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety Am. J. Obstet. Gynecol. 195 2006 270 274
52. M.F. Hebert, X. Ma, S.B. Naraharisetti, K.M. Krudys, J.G. Umans, G.D. Hankins, S.N. Caritis, M. Miodovnik, D.R. Mattison, J.D. Unadkat, E.J. Kelly, D. Blough, C. Cobelli, M.S. Ahmed, W.R. Snodgrass, D.B. Carr, T.R. Easterling, and P. Vicini Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice Clin. Pharmacol. Ther. 85 2009 607 614
53. D. Yeboah, G.M. Kalabis, M. Sun, R.C. Ou, S.G. Matthews, and W. Gibb Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term Reprod. Fertil. Dev. 20 2008 328 334
54. J. Stefulj, U. Panzenboeck, T. Becker, B. Hirschmugl, C. Schweinzer, I. Lang, G. Marsche, A. Sadjak, U. Lang, G. Desoye, and C. Wadsack Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1 Circ. Res. 104 2009 600 608
55. J.A. Keelan, I.L. Aye, P.J. Mark, and B.J. Waddell ABCA1 and placental cholesterol efflux Placenta 32 2011 708 709 author reply 710-701
56. J. Bhattacharjee, F. Ietta, E. Giacomello, N. Bechi, R. Romagnoli, A. Fava, and L. Paulesu Expression and localization of ATP binding cassette transporter A1 (ABCA1) in first trimester and term human placenta Placenta 31 2010 423 430
57. M.E. Baardman, W.S. Kerstjens-Frederikse, R.M. Berger, M.K. Bakker, R.M. Hofstra, and T. Plösch Biol. Reprod. 31 2013 24
58. L.A. Woollett Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation Am. J. Clin. Nutr. 82 2005 1155 1161
59. W.E. Connor, and D.S. Lin Placental transfer of cholesterol-4-14C into rabbit and guinea pig fetus J. Lipid Res. 8 1967 558 564
60. R.M. Pitkin, W.E. Connor, and D.S. Lin Cholesterol metabolism and placental transfer in the pregnant Rhesus monkey J. Clin. Invest. 51 1972 2584 2592
61. D.S. Lin, R.M. Pitkin, and W.E. Connor Placental transfer of cholesterol into the human fetus Am. J. Obstet. Gynecol. 128 1977 735 739
62. E.J. Plotz, J.J. Kabara, M.E. Davis, G.V. LeRoy, and R.G. Gould Studies on the synthesis of cholesterol in the brain of the human fetus Am. J. Obstet. Gynecol. 101 1968 534 538
63. G.S. Tint, M. Seller, R. Hughes-Benzie, A.K. Batta, S. Shefer, D. Genest, M. Irons, E. Elias, and G. Salen Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome J. Lipid Res. 36 1995 89 95
64. E. Herrera, E. Amusquivar, I. Lopez-Soldado, and H. Ortega Maternal lipid metabolism and placental lipid transfer Horm. Res. 65 Suppl. 3 2006 59 64
65. T.A. Christiansen-Weber, J.R. Voland, Y. Wu, K. Ngo, B.L. Roland, S. Nguyen, P.A. Peterson, and W.P. Fung-Leung Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency Am. J. Pathol. 157 2000 1017 1029
66. M. Denis, B. Haidar, M. Marcil, M. Bouvier, L. Krimbou, and J. Genest Jr. Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1) J. Biol. Chem. 279 2004 7384 7394
67. C.J. Fielding, and P.E. Fielding Cellular cholesterol efflux Biochim. Biophys. Acta 1533 2001 175 189
68. J. Lafond, M.C. Charest, J.F. Alain, L. Brissette, A. Masse, J. Robidoux, and L. Simoneau Presence of CLA-1 and HDL binding sites on syncytiotrophoblast brush border and basal plasma membranes of human placenta Placenta 20 1999 583 590
69. V. Drouineaud, P. Sagot, C. Garrido, E. Logette, V. Deckert, P. Gambert, C. Jimenez, B. Staels, L. Lagrost, and D. Masson Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists Mol. Hum. Reprod. 13 2007 373 379
70. J. Hempstock, E. Jauniaux, N. Greenwold, and G.J. Burton The contribution of placental oxidative stress to early pregnancy failure Hum. Pathol. 34 2003 1265 1275
71. A. Biri, M. Kavutcu, N. Bozkurt, E. Devrim, N. Nurlu, and I. Durak Investigation of free radical scavenging enzyme activities and lipid peroxidation in human placental tissues with miscarriage J. Soc. Gynecol. Investig. 13 2006 384 388
72. E. Bulgan Kilicdag, G. Ay, A. Celik, B. Ustundag, I. Ozercan, and M. Simsek Oxidant-antioxidant system changes relative to placental-umbilical pathology in patients with preeclampsia Hypertens. Pregnancy 24 2005 147 157
73. J. Vanderlelie, K. Venardos, V.L. Clifton, N.M. Gude, F.M. Clarke, and A.V. Perkins Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae Placenta 26 2005 53 58
74. A. Biri, N. Bozkurt, A. Turp, M. Kavutcu, O. Himmetoglu, and I. Durak Role of oxidative stress in intrauterine growth restriction Gynecol. Obstet. Invest. 64 2007 187 192
75. M.T. Coughlan, P.P. Vervaart, M. Permezel, H.M. Georgiou, and G.E. Rice Altered placental oxidative stress status in gestational diabetes mellitus Placenta 25 2004 78 84
76. M. Lappas, A. Mitton, and M. Permezel In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes J. Endocrinol. 204 2010 75 84
77. A.C. Maritim, R.A. Sanders, and J.B. Watkins 3rd Diabetes, oxidative stress, and antioxidants: a review J. Biochem. Mol. Toxicol. 17 2003 24 38
78. G.J. Burton, and E. Jauniaux Oxidative stress Best Pract. Res. Clin. Obstet. Gynaecol. 25 2011 287 299
79. T.H. Hung, L.M. Lo, T.H. Chiu, M.J. Li, Y.L. Yeh, S.F. Chen, and T.T. Hsieh A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation Reprod. Sci. 17 2010 401 409
80. L. Myatt, and X. Cui Oxidative stress in the placenta Histochem. Cell Biol. 122 2004 369 382
81. E. Jauniaux, J. Hempstock, N. Greenwold, and G.J. Burton Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies Am. J. Pathol. 162 2003 115 125
82. C.W. Redman, and I.L. Sargent Latest advances in understanding preeclampsia Science 308 2005 1592 1594
83. A. Meister Glutathione metabolism Methods Enzymol. 251 1995 3 7
84. M.E. Anderson Glutathione and glutathione delivery compounds Adv. Pharmacol. 38 1997 65 78
85. J. Martensson, A. Jain, and A. Meister Glutathione is required for intestinal function Proc. Natl. Acad. Sci. USA 87 1990 1715 1719
86. P. Borst, R. Evers, M. Kool, and J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins J. Natl. Cancer Inst. 92 2000 1295 1302
87. E.M. Leslie Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs) J. Inorg. Biochem. 108 2012 141 149
88. T. Watanabe, and S. Hirano Metabolism of arsenic and its toxicological relevance Arch. Toxicol. 2012 [EPub ahead of print]
89. M.W. Carew, and E.M. Leslie Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for the mutual detoxification of arsenic and selenium Carcinogenesis 31 2010 1450 1455
90. M.W. Carew, H. Naranmandura, C.B. Shukalek, X.C. Le, and E.M. Leslie Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1) Drug Metab. Dispos. 39 2011 2298 2304
91. S.S. Vaidya, S.W. Walsh, and P.M. Gerk Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments Mol. Pharm. 6 2009 1689 1702
92. E.E. Dubinina, and V.A. Dadali Role of 4-hydroxy-trans-2-nonenal in cell functions Biochemistry (Mosc.) 75 2010 1069 1087
93. A. Casasco, A. Calligaro, M. Casasco, S. Tateo, A. Icaro Cornaglia, M. Reguzzoni, and A. Farina Immunohistochemical localization of lipoperoxidation products in normal human placenta Placenta 18 1997 249 253
94. D.I. Santoso, P. Rogers, E.M. Wallace, U. Manuelpillai, D. Walker, and S.B. Subakir Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae Placenta 23 2002 373 379
95. B.H. Fryer, and M.C. Simon Hypoxia HIF and the placenta Cell Cycle 5 2006 495 498
96. P. Ugocsai, A. Hohenstatt, G. Paragh, G. Liebisch, T. Langmann, Z. Wolf, T. Weiss, P. Groitl, T. Dobner, P. Kasprzak, L. Gobolos, A. Falkert, B. Seelbach-Goebel, A. Gellhaus, E. Winterhager, M. Schmidt, G.L. Semenza, and G. Schmitz HIF-1beta determines ABCA1 expression under hypoxia in human macrophages Int. J. Biochem. Cell Biol. 42 2010 241 252
97. T. Plosch, A. Gellhaus, E.M. van Straten, N. Wolf, N.C. Huijkman, M. Schmidt, C.E. Dunk, F. Kuipers, and E. Winterhager The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: a reason for alterations in preeclampsia? Placenta 31 2010 910 918
98. C. Albrecht, S. Soumian, N. Tetlow, P. Patel, M.H. Sullivan, L. Lakasing, K. Nicolaides, and C. Williamson Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to pre-eclampsia and controls Placenta 28 2007 701 708
99. Y.J. Kim, H. Park, H.Y. Lee, Y.M. Ahn, E.H. Ha, S.H. Suh, and M.G. Pang Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia Eur. J. Obstet. Gynecol. Reprod. Biol. 133 2007 47 52
100. C. Qiu, T.T. Phung, S. Vadachkoria, M. Muy-Rivera, S.E. Sanchez, and M.A. Williams Oxidized low-density lipoprotein (oxidized LDL) and the risk of preeclampsia Physiol. Res. 55 2006 491 500
101. S.E. Sanchez, M.A. Williams, M. Muy-Rivera, C. Qiu, S. Vadachkoria, and V. Bazul A case-control study of oxidized low density lipoproteins and preeclampsia risk Gynecol. Endocrinol. 21 2005 193 199
102. H. Uzun, A. Benian, R. Madazli, M.A. Topcuoglu, S. Aydin, and M. Albayrak Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia Gynecol. Obstet. Invest. 60 2005 195 200
103. A.J. Brown, and W. Jessup Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis Mol. Aspects Med. 30 2009 111 122
104. M.A. Lyons, and A.J. Brown 7-Ketocholesterol Int. J. Biochem. Cell Biol. 31 1999 369 375
105. S.R. Panini, and M.S. Sinensky Mechanisms of oxysterol-induced apoptosis Curr. Opin. Lipidol. 12 2001 529 533
106. I. Bjorkhem Are side-chain oxidized oxysterols regulators also in vivo? J. Lipid Res. 50 Suppl. 2009 S213 S218
107. B. Dugas, S. Charbonnier, M. Baarine, K. Ragot, D. Delmas, F. Menetrier, J. Lherminier, L. Malvitte, T. Khalfaoui, A. Bron, C. Creuzot-Garcher, N. Latruffe, and G. Lizard Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol Eur. J. Nutr. 49 2010 435 446
108. F. Morello, E. Saglio, A. Noghero, D. Schiavone, T.A. Williams, A. Verhovez, F. Bussolino, F. Veglio, and P. Mulatero LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms Atherosclerosis 207 2009 38 44
109. I.L. Aye, B.J. Waddell, P.J. Mark, and J.A. Keelan Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterol-sensitive activation of NF-kappaB Mol. Hum. Reprod. 18 2012 341 353
110. L. Pavan, A. Hermouet, V. Tsatsaris, P. Therond, T. Sawamura, D. Evain-Brion, and T. Fournier Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors Endocrinology 145 2004 4583 4591
111. L. Pavan, V. Tsatsaris, A. Hermouet, P. Therond, D. Evain-Brion, and T. Fournier Oxidized low-density lipoproteins inhibit trophoblastic cell invasion J. Clin. Endocrinol. Metab. 89 2004 1969 1972
112. I.L. Aye, B.J. Waddell, P.J. Mark, and J.A. Keelan Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors Placenta 32 2011 183 191
113. A.C. Valbuena-Diez, F.J. Blanco, B. Oujo, C. Langa, M. Gonzalez-Nunez, E. Llano, A.M. Pendas, M. Diaz, A. Castrillo, J.M. Lopez-Novoa, and C. Bernabeu Oxysterol-induced soluble endoglin release and its involvement in hypertension Circulation 126 2012 2612 2624
114. W. Gaoua, F. Chevy, C. Roux, and C. Wolf Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome J. Lipid Res. 40 1999 456 463
115. M.M. Beyea, C.L. Heslop, C.G. Sawyez, J.Y. Edwards, J.G. Markle, R.A. Hegele, and M.W. Huff Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol J. Biol. Chem. 282 2007 5207 5216
116. P. Costet, Y. Luo, N. Wang, and A.R. Tall Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor J. Biol. Chem. 275 2000 28240 28245
117. C.M. Martin, A. Ferdous, T. Gallardo, C. Humphries, H. Sadek, A. Caprioli, J.A. Garcia, L.I. Szweda, M.G. Garry, and D.J. Garry Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells Circ. Res. 102 2008 1075 1081
118. P. Krishnamurthy, D.D. Ross, T. Nakanishi, K. Bailey-Dell, S. Zhou, K.E. Mercer, B. Sarkadi, B.P. Sorrentino, and J.D. Schuetz The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme J. Biol. Chem. 279 2004 24218 24225
119. H. Wang, X. Wu, K. Hudkins, A. Mikheev, H. Zhang, A. Gupta, J.D. Unadkat, and Q. Mao Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors Am. J. Physiol. Endocrinol. Metab. 291 2006 E1295 1304
120. D.A. Evseenko, P. Murthi, J.W. Paxton, G. Reid, B.S. Emerald, K.M. Mohankumar, P.E. Lobie, S.P. Brennecke, B. Kalionis, and J.A. Keelan The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction FASEB J. 21 2007 3592 3605
121. K.G. Birukov Oxidized lipids: the two faces of vascular inflammation Curr. Atheroscler. Rep. 8 2006 223 231
122. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J. Clin. Invest. 116 2006 3015 3025
123. M.R. Peltier Immunology of term and preterm labor Reprod. Biol. Endocrinol. 1 2003 122
124. J.A. Keelan, K.W. Marvin, T.A. Sato, M. Coleman, L.M. McCowan, and M.D. Mitchell Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition Am. J. Obstet. Gynecol. 181 1999 1530 1536
125. A. Steinborn, H. Gunes, S. Roddiger, and E. Halberstadt Elevated placental cytokine release, a process associated with preterm labor in the absence of intrauterine infection Obstet. Gynecol. 88 1996 534 539
126. R. Romero, C. Avila, U. Santhanam, and P.B. Sehgal Amniotic fluid interleukin 6 in preterm labor. Association with infection J. Clin. Invest. 85 1990 1392 1400
127. A. Szarka, J. Rigo Jr., L. Lazar, G. Beko, and A. Molvarec Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array BMC Immunol. 11 2010 59
128. A. Zarubica, D. Trompier, and G. Chimini ABCA1, from pathology to membrane function Pflugers Arch. 453 2007 569 579
129. I.L.M.H. Aye, Cholesterol and oxysterol transport in human placental trophoblasts: implications for placental cell viability, differentiation and inflammation, Thesis (Ph.D.), University of Western Australia, 2011.
130. D.A. Evseenko, J.W. Paxton, and J.A. Keelan Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors Drug Metab. Dispos. 35 2007 595 601
131. M. von Wedel-Parlow, P. Wolte, and H.J. Galla Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro J. Neurochem. 111 2009 111 118
132. A.M. Belliard, B. Lacour, R. Farinotti, and C. Leroy Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells J. Pharm. Sci. 93 2004 1524 1536
133. G. Lee, and M. Piquette-Miller Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays J. Pharm. Sci. 92 2003 2152 2163
134. V. Petrovic, J.H. Wang, and M. Piquette-Miller Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats Drug Metab. Dispos. 36 2008 1944 1950
135. C.W. Mason, I.A. Buhimschi, C.S. Buhimschi, Y. Dong, C.P. Weiner, and P.W. Swaan ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition Drug Metab. Dispos. 39 2011 1000 1007
136. R.X. Davey Gestational diabetes mellitus: a review from Curr. Diab. Rev. 1 2005 2004 203 213
137. R. Schwartz, and K.A. Teramo Effects of diabetic pregnancy on the fetus and newborn Semin. Perinatol. 24 2000 120 135
138. M.S. Islam, and T. Loots du Experimental rodent models of type 2 diabetes: a review Methods Find Exp. Clin. Pharmacol. 31 2009 249 261
139. G.J. Anger, L. Magomedova, and M. Piquette-Miller Impact of acute streptozotocin-induced diabetes on ABC transporter expression in rats Chem. Biodivers. 6 2009 1943 1959
140. W. Tang, C. Yi, J. Kalitsky, and M. Piquette-Miller Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats Mol. Cell Biol. Res. Commun. 4 2000 90 97
141. H. Liu, H. Yang, D. Wang, Y. Liu, X. Liu, Y. Li, L. Xie, and G. Wang Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway Eur. J. Pharmacol. 602 2009 277 282
142. X. Liu, X.Y. Jing, S. Jin, Y. Li, L. Liu, Y.L. Yu, X.D. Liu, and L. Xie Insulin suppresses the expression and function of breast cancer resistance protein in primary cultures of rat brain microvessel endothelial cells Pharmacol. Rep. 63 2011 487 493
143. Y. Zhang, C. Li, X. Sun, X. Kuang, and X. Ruan High glucose decreases expression and activity of P-glycoprotein in cultured human retinal pigment epithelium possibly through iNOS induction PLoS One 7 2012 e31631
144. R. Mauerer, S. Ebert, and T. Langmann High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages Exp. Mol. Med. 41 2009 126 132
145. A. Gantman, B. Fuhrman, M. Aviram, and T. Hayek High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx Biochem. Biophys. Res. Commun. 391 2010 523 528
146. D.C. Patel, C. Albrecht, D. Pavitt, V. Paul, C. Pourreyron, S.P. Newman, I.F. Godsland, J. Valabhji, and D.G. Johnston Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function PLoS One 6 2011 e22142
147. J.P. Mauldin, M.H. Nagelin, A.J. Wojcik, S. Srinivasan, M.D. Skaflen, C.R. Ayers, C.A. McNamara, and C.C. Hedrick Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus Circulation 117 2008 2785 2792
148. K. Nonomura, Y. Arai, H. Mitani, S. Abe-Dohmae, and S. Yokoyama Insulin down-regulates specific activity of ATP-binding cassette transporter A1 for high density lipoprotein biogenesis through its specific phosphorylation Atherosclerosis 216 2011 334 341
149. Y. Uehara, T. Engel, Z. Li, C. Goepfert, S. Rust, X. Zhou, C. Langer, C. Schachtrup, J. Wiekowski, S. Lorkowski, G. Assmann, and A. von Eckardstein Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1 Diabetes 51 2002 2922 2928
150. C. Gedeon, J. Behravan, G. Koren, and M. Piquette-Miller Transport of glyburide by placental ABC transporters: implications in fetal drug exposure Placenta 27 2006 1096 1102
151. C. Gedeon, G. Anger, M. Piquette-Miller, and G. Koren Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta Placenta 29 2008 39 43
152. E. Pollex, A. Lubetsky, and G. Koren The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta Placenta 29 2008 743 747
153. W. Nicholson, and K. Baptiste-Roberts Oral hypoglycaemic agents during pregnancy: the evidence for effectiveness and safety Best Pract. Res. Clin. Obstet. Gynaecol. 25 2011 51 63
154. J.R. Seckl, and M.C. Holmes Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology Nat. Clin. Pract. Endocrinol. Metab. 3 2007 479 488
155. P.J. Burton, and B.J. Waddell Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action Biol. Reprod. 60 1999 234 240
156. P.J. Mark, S. Augustus, J.L. Lewis, D.P. Hewitt, and B.J. Waddell Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone Biol. Reprod. 80 2009 1209 1215
157. P.J. Mark, and B.J. Waddell P-glycoprotein restricts access of cortisol and dexamethasone to the glucocorticoid receptor in placental BeWo cells Endocrinology 147 2006 5147 5152